Physician profile
Patrick J Kellam
NPI 1386006146
$55,459.52
in general payments reported to CMS, 2019-2025
9 companies · $18K in 2025
The $18K reported for 2025 was more than what 84% of Orthopaedic Trauma providers received nationally (typical 2025 total: $1,227).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $15K · 2022: $11K · 2023: $7,989 · 2024: $3,905 · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $9,751 · Education: $5,021 · Travel and Lodging: $2,862.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,875.00 |
| Food and Beverage | $9,751.05 |
| Education | $5,020.72 |
| Travel and Lodging | $2,862.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $17,682.82 | 2021-2023 | Evos, Tandem, Trigen Intertan |
| Globus Medical, INC. | $14,910.29 | 2022-2025 | Autobahn, Anthem, Autobahn |
| Arthrex, INC. | $11,593.12 | 2021 | |
| Stryker Corporation | $5,831.37 | 2022-2025 | Gamma, T2 Alpha, Axsos |
| Depuy Synthes Sales INC. | $3,908.01 | 2022-2025 | Na, Tfn-Advance, Va-Lcp |
| Medical Device Business Services, INC. | $654.66 | 2022-2025 | Tfn-Advance |
| Medinc of Texas | $645.20 | 2022-2025 | |
| Onkos Surgical, INC. | $133.95 | 2024 | Eleos Limb Salvage System |
| Next Science LLC | $100.10 | 2025 | Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Patrick Kellam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.